Jonathan Groff in Just In Time on Broadway 2026

Just in Time Recoups Its $12.5 Million Investment — Here's What Broadway Investors Should Know

May 20, 20264 min read

There's a milestone that every Broadway investor is watching for... the moment when the show they backed stops burning through its capitalization and starts returning money.

For the 2024-2025 Broadway season, Just in Time got there first.

The Bobby Darin jukebox musical, which opened at Circle in the Square Theatre on April 26, 2025, has officially recouped its $12.5 million capitalization, becoming the first musical of its season to do so. It broke weekly box office records at its venue multiple times along the way.


Recoupment: A Refresher

Broadway recoupment is the point at which a show has earned back its full production investment. Every dollar raised to develop, rehearse, build, market, and open the show needs to come back in before investors see profit.

That includes:

  • Pre-production development

  • Set construction and technical costs

  • Rehearsal period salaries

  • Advertising and marketing campaigns

  • Early operating losses before the show finds its audience

Historically, only about 20-25% of Broadway productions recoup. Musicals face an even steeper climb — they cost more to mount and more to run every week. A $12.5 million capitalization is a substantial bar to clear.

Just in Time cleared it. And it's worth understanding exactly how.


What Made This Show Work as an Investment

1. Jonathan Groff Is Both Star and Stakeholder

When the lead actor is also a producer, interests align in a different way. Groff had a financial reason to drive every element of the show's success — from his own performance to how the production was positioned in the market. That kind of alignment matters.

His Tony nomination also fueled awareness at exactly the moment awards season generates peak box office attention.

2. The Venue Was the Right Fit

Circle in the Square is a unique Broadway house, an in-the-round configuration that creates an intimate, immersive experience unavailable anywhere else on Broadway. Just in Time was programmed specifically for that space. Venue-show fit is an underrated variable in how productions perform. When a show feels made for its theater, audiences feel it.

3. Strong Cast Succession

Jonathan Groff's Broadway run was always going to be limited. Matthew Morrison and then Jeremy Jordan stepped in, each bringing their own fanbase and keeping weekly grosses strong. Olivia Holt is scheduled to join the cast, extending the show's ability to generate headlines and demand.

👉 Cast succession is a signal that a show has been designed for longevity, not just an opening night.

4. The Awards Attention Was Sustained

Six Tony nominations and nine Drama Desk nominations don't just generate press, they keep a show in weekly conversations and drive group sales from theatergoers who want to see what all the attention is about. A Grammy nomination for Best Musical Theater Album adds a revenue and visibility stream that most shows never see.

5. There's a Tour Coming

A North American tour launching in June 2027 is more than an expansion. It's a signal that the show has commercial legs — that producers believe the demand exists outside New York, and that the IP has earned its place in the touring market. Tour income flows back through the production structure, continuing to benefit investors.


The $12.5 Million Question

Recouping a $12.5 million musical on Broadway is genuinely difficult. Musicals carry higher weekly costs, larger casts, more complex technical demands, and more marketing pressure than straight plays. The math requires sustained, strong box office over a long period.

Just in Time got there through a combination of smart casting, venue alignment, awards momentum, and a built-in audience for Bobby Darin's catalog. None of those factors were accidents. Each was a producing decision made before the curtain ever went up.


What Investors Can Learn From This

The shows that recoup tend to have deliberate structures underneath the entertainment. Low operating costs. Clear audience targets. Star power that extends beyond opening night. Subject matter with a pre-existing fan base.

Just in Time hit most of those marks. The producing team — Tom Kirdahy, Robert Ahrens, and John Frost — built a production that could sustain itself past the honeymoon period. That's harder than it looks.

Every time a musical recoups, it adds a data point to what actually works on Broadway. The patterns are worth studying.

What do you look for when evaluating a jukebox musical as a Broadway investment? Share your thinking in the comments.


Back to Blog